Silk Road Medical, Inc. Common Stock
SILK
SILK was delisted on the 16th of September, 2024.
139 hedge funds and large institutions have $1.34B invested in Silk Road Medical, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 53 increasing their positions, 49 reducing their positions, and 26 closing their positions.
92% more call options, than puts
Call options by funds: $5.17M | Put options by funds: $2.69M
8% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 49
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
9% less funds holding
Funds holding: 153 → 139 (-14)
10% less capital invested
Capital invested by funds: $1.5B → $1.34B (-$154M)
38% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 26
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$19M |
| 2 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$9.43M |
| 3 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$6.94M |
| 4 |
American Century Companies
Kansas City,
Missouri
|
+$6.54M |
| 5 |
BAMCO Inc
New York
|
+$6.32M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
-$11.9M |
| 2 |
CIBC Asset Management
Toronto,
Ontario, Canada
|
-$9.31M |
| 3 |
Jennison Associates
New York
|
-$8.52M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$6.36M |
| 5 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$5.33M |
SILK Hedge Fund Activity: Q2 2022 in Review
139 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Silk Road Medical, Inc. Common Stock (SILK) for Q2 2022, worth a combined $1.34B — down 10% from $1.5B a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of SILK and 16 opened new positions — a net loss of 10 holders — while 49 trimmed existing stakes and 53 added.
The largest buyer was Deerfield Management, adding an estimated $19M. The largest seller was Balyasny Asset Management, exiting entirely with an estimated $11.9M sold.
- 139 institutional investors held Silk Road Medical, Inc. Common Stock (SILK) as of Q2 2022, down from 153 in Q1 2022.
- Funds reported $1.34B of Silk Road Medical, Inc. Common Stock stock for Q2 2022, down 10% quarter-over-quarter.
- 16 funds opened new Silk Road Medical, Inc. Common Stock positions in Q2 2022 and 26 closed out, a net change of -10 holders.
- The largest Silk Road Medical, Inc. Common Stock buyer in Q2 2022 was Deerfield Management, an estimated $19M added.
- The largest Silk Road Medical, Inc. Common Stock seller in Q2 2022 was Balyasny Asset Management, an estimated $11.9M sold.
Based on aggregated 13F filings for Q2 2022.